GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (OTCPK:NSHSF) » Definitions » Momentum Rank

Nanosphere Health Sciences (Nanosphere Health Sciences) Momentum Rank : 0 (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Nanosphere Health Sciences Momentum Rank?

Nanosphere Health Sciences has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Nanosphere Health Sciences Momentum Rank Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere Health Sciences (Nanosphere Health Sciences) Business Description

Traded in Other Exchanges
Address
1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.